Flolan



Indications and Reactions:

Role Indications Reactions
Primary
Pulmonary Arterial Hypertension 36.0%
Pulmonary Hypertension 23.1%
Product Used For Unknown Indication 20.2%
Drug Use For Unknown Indication 8.9%
Cor Pulmonale Chronic 3.9%
Cardiac Failure 2.0%
Essential Hypertension 0.8%
Pain 0.7%
Prophylaxis 0.6%
Right Ventricular Failure 0.6%
Connective Tissue Disorder 0.5%
Cough 0.4%
Collagen Disorder 0.3%
Sedation 0.3%
Postoperative Care 0.3%
Eisenmenger's Syndrome 0.3%
Heart Disease Congenital 0.3%
Hypertension 0.3%
Infection Prophylaxis 0.3%
Pulmonary Embolism 0.3%
Death 18.8%
Pharmaceutical Product Complaint 17.6%
Vomiting 5.6%
Pneumonia 5.2%
Pain In Jaw 5.0%
Dyspnoea 4.2%
Pyrexia 3.9%
Thrombocytopenia 3.9%
Rash 3.8%
Device Related Infection 3.4%
Diarrhoea 3.4%
Weight Increased 3.4%
Weight Decreased 3.1%
Pulmonary Hypertension 3.0%
Pain In Extremity 2.8%
Medical Device Complication 2.7%
Platelet Count Decreased 2.7%
Right Ventricular Failure 2.7%
Tachycardia 2.6%
Ascites 2.4%
Secondary
Pulmonary Arterial Hypertension 33.5%
Pulmonary Hypertension 18.4%
Product Used For Unknown Indication 8.5%
Prophylaxis 4.1%
Cor Pulmonale Chronic 4.0%
Drug Use For Unknown Indication 4.0%
Cough 4.0%
Prophylaxis Against Gastrointestinal Ulcer 3.0%
Thrombosis Prophylaxis 2.8%
Infection Prophylaxis 2.7%
Osteoporosis Prophylaxis 2.7%
Anxiety 2.1%
Diarrhoea 2.1%
Prophylaxis Against Diarrhoea 2.1%
Cardiac Failure 1.9%
Right Ventricular Failure 1.1%
Primary Pulmonary Hypertension 1.0%
Collagen Disorder 0.9%
Ill-defined Disorder 0.6%
Hyperthyroidism 0.5%
Pneumonia 18.6%
Death 15.3%
Pulmonary Congestion 7.6%
White Blood Cell Count Decreased 5.5%
Urticaria 5.1%
Ventricular Tachycardia 5.1%
Vomiting 4.7%
Weight Decreased 4.7%
Device Related Infection 3.4%
Pain In Extremity 3.4%
Cardiac Failure 3.0%
Lung Transplant 3.0%
Pulmonary Alveolar Haemorrhage 3.0%
Pulmonary Hypertension 3.0%
Thrombocytopenia 3.0%
Treatment Noncompliance 3.0%
Right Ventricular Failure 2.5%
Coronary Artery Disease 2.1%
Hypotension 2.1%
Sinus Rhythm 2.1%
Concomitant
Pulmonary Arterial Hypertension 45.2%
Pulmonary Hypertension 22.0%
Product Used For Unknown Indication 18.5%
Prophylaxis 1.3%
Vitamin Supplementation 1.1%
Cardiac Failure 1.1%
Pain 1.1%
Drug Use For Unknown Indication 1.0%
Anticoagulant Therapy 0.9%
Asthma 0.9%
Right Ventricular Failure 0.8%
Arrhythmia 0.8%
Immunosuppression 0.8%
Cor Pulmonale Chronic 0.7%
Scleroderma 0.7%
Coronary Artery Bypass 0.6%
Hypokalaemia 0.6%
Pneumonia 0.6%
Rheumatoid Arthritis 0.6%
Infection Prophylaxis 0.6%
Death 14.9%
Right Ventricular Failure 13.4%
Vomiting 7.8%
Pulmonary Arterial Hypertension 7.5%
Cardiac Failure 5.6%
Device Related Infection 5.6%
Dyspnoea 4.3%
Pulmonary Hypertension 4.3%
Pneumonia 4.0%
Pregnancy 3.7%
Hepatic Function Abnormal 3.4%
Syncope 3.4%
Lung Transplant 3.1%
Nausea 3.1%
Oedema 3.1%
Thrombocytopenia 2.8%
Chest Pain 2.5%
Oedema Peripheral 2.5%
Restlessness 2.5%
Scleroderma 2.5%
Interacting
Pulmonary Hypertension 100.0%
Rash 50.0%
Vomiting 50.0%